公司資料
Omeros 股價、新聞與催化劑
- 股票代碼:
- OMER
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
19.32 USD (+0.26%)
收盤價
最後更新: 2026年8月24日
743M USD
市值
股價為何變動
As of Aug 24, 2026, OMER closed up 0.26% at $19.32. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Omeros is a biotechnology company with programs in immunology, complement biology, and rare disease. The company has long been defined by a mix of scientific ambition and a complicated commercial path.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Omeros sits in specialty biotechnology.
商業模式特徵
The business depends on clinical validation, portfolio management, and the ability to unlock value from a narrow set of programs.
生技產業定位
Omeros is a high-uncertainty biotech name whose valuation is driven by pipeline outcomes and strategic progress.
未來催化劑
- Omeros’s catalysts are narsoplimab and the remaining complement / immunology assets. Investors will focus on whether the company can still turn its late-stage biology into something commercially relevant.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。